Aytu BioPharma Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	26.72	30.95	20.01	22.99	19.36	49.65
Cash & Short-Term Investments	26.72	30.95	20.01	22.99	19.36	49.65
Cash Growth	47.00%	54.71%	-12.96%	18.72%	-61.01%	3.26%
Accounts Receivable	24.49	31.16	23.53	28.94	21.71	28.18
Inventory	7.46	11.43	12.14	12	10.85	16.34
Other Current Assets	8.66	5.64	6.22	7.16	8.01	11.07
Total Current Assets	67.33	79.18	61.89	71.08	59.93	105.23
Net Property, Plant & Equipment	1.32	1.59	1.52	3.87	6.3	8.7
Other Intangible Assets	42.49	42.2	52.45	58.97	70.63	85.46
Goodwill	-	-	-	-	-	65.8
Other Long-Term Assets	0.56	1.2	2.23	2.55	0.77	0.47
Total Assets	111.69	124.18	118.1	136.46	137.62	265.67
Accounts Payable	13.21	10.6	10.31	13.48	10.99	19.26
Accrued Expenses	34.27	38.16	38.14	46.8	44.19	57.23
Short-Term Debt	10.41	9.06	2.4	1.56	3.81	7.93
Current Portion of Long-Term Debt	1.86	1.86	1.86	0.09	0.1	16.67
Other Current Liabilities	0.22	3.38	9.52	7.09	5.36	8.35
Total Current Liabilities	59.97	63.06	62.23	69.02	64.44	109.44
Long-Term Debt	9.55	10.9	10.88	14.71	14.28	0.18
Other Long-Term Liabilities	7.03	31.25	17.27	13.38	14.59	18.48
Total Long-Term Liabilities	16.57	42.15	28.15	28.09	28.87	18.66
Total Liabilities	76.55	105.21	90.38	97.11	93.32	128.1
Common Stock	0	0	0	0	0	0
Additional Paid-in Capital	382.91	352.5	347.69	343.49	331.39	315.86
Retained Earnings	-347.77	-333.54	-319.97	-304.13	-287.08	-178.3
Shareholders' Equity	35.14	18.97	27.72	39.36	44.31	137.57
Total Liabilities & Equity	111.69	124.18	118.1	136.46	137.62	265.67
Total Debt	21.82	21.82	15.13	16.36	18.19	24.78
Net Cash (Debt)	4.9	9.14	4.88	6.62	1.17	24.87
Net Cash Growth	-46.39%	87.35%	-26.37%	465.19%	-95.29%	-46.03%
Net Cash Per Share	0.42	1.46	0.88	1.98	0.80	29.70
Book Value	35.14	18.97	27.72	39.36	44.31	137.57
Book Value Per Share	3.00	3.02	5.00	11.78	30.14	164.29
Tangible Book Value	-7.35	-23.24	-24.74	-19.61	-26.32	-13.7
Tangible Book Value Per Share	-0.63	-3.70	-4.47	-5.87	-17.91	-16.36

SEC Filings: 10-K · 10-Q